Continuous Biomonitoring Will Reveal That Most 'Aging Biomarkers' Are Actually Snapshot Artifacts

We're measuring aging like photographers trying to capture a river—frozen frames that miss the flow. What if the most important biological changes happen in the dynamics, not the levels?
I propose that continuous biomonitoring (wearables + implantable microsensors + metabolic flux tracking) will reveal that our current 'gold standard' aging biomarkers are capturing endpoint states, not the rate-limiting processes.